Shoib Sarwar Siddiqui

7PUBLICATIONS
17CO-AUTHORS
Characterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2025
New chalcone compound exhibits microrna-mediated anticancer properties in glioblastoma.

Denis Mustafov, Shoib S Siddiqui, Irshad Ahmad

|Sep 30, 2024
Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression.

Mohammed Saqif Ahmad, Maria Braoudaki, Shoib Sarwar Siddiqui

|Dec 23, 2022
Plant Flavonoids on Oxidative Stress-Mediated Kidney Inflammation.

Seba Alsawaf, Fatema Alnuaimi, Saba Afzal

|Feb 22, 2021
Human-specific polymorphic pseudogenization of SIGLEC12 protects against advanced cancer progression.

Shoib S Siddiqui, Michael Vaill, Raymond Do

|Dec 08, 2020
Natural compound catechol induces DNA damage, apoptosis, and G1 cell cycle arrest in breast cancer cells.

Cijo George Vazhappilly, Rawad Hodeify, Shoib Sarwar Siddiqui

|Nov 30, 2020
Tools to study and target the Siglec-sialic acid axis in cancer.

Heinz Läubli, Kunio Kawanishi, Cijo George Vazhappilly

Pageof 2

Frequent Collaborators

3 joint publications

Cijo George Vazhappilly

1 joint publications

Michael Vaill

1 joint publications

Raymond Do

1 joint publications

Naazneen Khan